CymitQuimica logo

CAS 1195941-38-8

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits trouvés.
  • Edg-2 receptor inhibitor 1

    CAS :
    Edg-2 receptor inhibitor 1 (SAR-100842) is an Edg-2 receptor inhibitor extracted (IC50: <0.1 μM).
    Formule :C27H27NO5
    Degré de pureté :99.47%
    Couleur et forme :Solid
    Masse moléculaire :445.51

    Ref: TM-T4521

    1mg
    92,00€
    2mg
    166,00€
    5mg
    259,00€
    1mL*10mM (DMSO)
    273,00€
    10mg
    404,00€
    25mg
    628,00€
    50mg
    897,00€
    100mg
    1.198,00€
  • Edg-2 receptor inhibitor 1

    CAS :
    Edg-2 receptor inhibitor 1
    Formule :C27H27NO5
    Degré de pureté :≥98%
    Masse moléculaire :445.51

    Ref: 54-BUP05601

    2mg
    254,00€
    5mg
    390,00€
    10mg
    598,00€
    25mg
    911,00€
    50mg
    1.201,00€
    100mg
    1.577,00€
  • SAR-100842

    CAS :
    2-(4-Methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid
    Formule :C27H27NO5
    Degré de pureté :98%
    Masse moléculaire :445.51
  • 2,3-Dihydro-2-[[4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzoyl]amino]-1H-Indene-2-carboxylic Acid

    CAS :
    2,3-Dihydro-2-[[4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzoyl]amino]-1H-Indene-2-carboxylic Acid (MK0893) is a small molecule that belongs to the class of indole carboxamides. It is a potent and selective inhibitor of phosphodiesterase 1 (PDE1), with an IC50 value of less than 10 nM. MK0893 inhibits PDE1 in vitro and in vivo, leading to increased cAMP levels, vasodilation, and induction of nitric oxide synthase. MK0893 has been shown to have therapeutic efficacy in animal models of systemic sclerosis. In these models, MK0893 inhibited the development of skin fibrosis by inhibiting TGFβ signaling, which is implicated in the pathogenesis of systemic sclerosis.
    Formule :C27H27NO5
    Degré de pureté :Min. 95%
    Masse moléculaire :445.51 g/mol

    Ref: 3D-VXB94138

    50mg
    1.823,00€
    500mg
    5.816,00€